Developing and Commercializing a Powerful and Enabling PCT Platform
Pressure BioSciences is a life sciences company focused on the development and commercialization of a novel, enabling platform technology called Pressure Cycling Technology ("PCT"). PCT uses cycles of hydrostatic pressure between ambient and ultra-high levels (up to 35,000 psi and greater) to control bio-molecular interactions.
Internally Developed Instrument and Consumable Product Line
Pressure Cycling Technology with Potential for Broad Applications
Our pressure cycling technology employs a unique approach that we believe has the potential for broad applications in a number of established and emerging life sciences areas, including:
- Sample preparation for genomic, proteomic, and small molecule studies;
- Pathogen inactivation;
- Protein purification;
- Control of chemical (enzymatic) reactions; and
Our Business Strategy
Since we began operations as Pressure BioSciences in February 2005, we have focused substantially all of our research and development, and commercialization efforts on sample preparation for genomic, proteomic and small molecule studies.
Our business strategy is to commercialize pressure cycling technology in the area of sample preparation for genomic, proteomic and small molecule studies ("sample preparation"). We also plan to pursue the further development and commercialization of PCT in other life sciences applications, which could include working with various strategic partners that have greater scientific and regulatory expertise in the respective applications than we do.